Pre-op breast pain in about 28 percent of breast cancer patients

June 15, 2012
Pre-op breast pain in about 28 percent of breast cancer patients
More than a quarter of women about to undergo breast cancer surgery experience breast pain, with genetic polymorphisms in inflammatory cytokines correlating with pain, according to a study published in the May issue of The Journal of Pain.

(HealthDay) -- More than a quarter of women about to undergo breast cancer surgery experience breast pain, with genetic polymorphisms in inflammatory cytokines correlating with pain, according to a study published in the May issue of The Journal of Pain.

Birha McCann, R.N., C.N.S., of the University of California in San Francisco, and associates recruited 398 women with breast cancer prior to surgery to determine the occurrence rate and characteristics of preoperative breast pain. The women completed self-report questionnaires and were genotyped. Variations in pro- and anti-inflammatory cytokine genes were assessed for those who did and did not report pain.

The researchers found that 28.2 percent of women self-reported breast pain. These women were significantly younger (P < 0.001), were more likely to be nonwhite (P = 0.032), were less likely to be postmenopausal (P = 0.012), reported lower Karnofsky Performance Status scores (P = 0.008), and had undergone more biopsies (P = 0.006). Presurgical breast pain was significantly less likely for carriers of the minor allele for a single nucleotide polymorphism in interleukin (IL)1-receptor 1 and significantly more likely for carriers of the minor allele of a single nucleotide polymorphism in IL13.

"Findings suggest that breast pain occurs in over a quarter of women who are about to undergo ," the authors write. "Based on phenotypic and genotypic characteristics found, inflammatory mechanisms contribute to preoperative ."

Explore further: Research finds little benefit of breast imaging tests for women with breast pain

More information: Abstract
Full Text (subscription or payment may be required)


Related Stories

Research finds little benefit of breast imaging tests for women with breast pain

March 7, 2012
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that women with breast pain who receive imaging (mammograms, MRIs or ultrasounds) as part of breast pain evaluation, ...

Polymorphism in opioid gene affects breast cancer survival

March 30, 2012
(HealthDay) -- Genotype at the A118G polymorphism of the µ-opioid receptor gene is associated with breast cancer-specific mortality, according to a study published in the April issue of Anesthesiology.

A third of women with secondary breast cancer are needlessly living in pain, research shows

November 22, 2011
(Medical Xpress) -- New research released today by Breast Cancer Care and the University of Southampton reveals that more than a third (34 per cent) of women with secondary breast cancer are unnecessarily living with uncontrolled ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.